The latest momentum in investing equities points to a tech-led rebound, with Nasdaq up 2.1% this week. Analysts forecast Q3 earnings growth of 8% year-over-year in AI and semiconductor sectors, suggesting capital rotation toward growth names. As a next step, we compared Jin Medical International's net income growth with the industry and were disappointed to see that the company's growth is lower than the industry average growth of 14% in the same period. Any views, strategies or products discussed in this content may not be appropriate for all individuals and are subject to risks. Investors may get back less than they invested, and past performance is not a reliable indicator of future results. Asset allocation/diversification does not guarantee a profit or protect against loss. Nothing in this content should be relied upon in isolation for the purpose of making an investment decision. You are urged to consider carefully whether the services, products, asset classes (e.g., equities, fixed income, alternative investments, commodities, etc.) or strategies discussed are suitable to your needs. You must also consider the objectives, risks, charges, and expenses associated with an investment service, product or strategy prior to making an investment decision. For this and more complete information, including discussion of your goals/situation, contact your J.P. Morgan team. Infrastructure investing equities are up 2% on government spending initiatives. Public project pipelines drive order books higher for construction and engineering firms.
